TSE:141A stock news
This page provides real-time market news, earnings updates, and company announcements related to TRIAL Holdings.Inc. (TSE:141A).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-05-29 05:51 JST
In the latest clinical trial data released by Hoth Therapeutics, more than 65% of participants reported significant improvement in pain and itching symptoms.
老虎证券2026-05-05 20:23:28
Cadrenal Therapeutics, Inc. released its financial results for the first quarter of 2026 and provided updates on the Phase III clinical trial plans for its core drug, CAD-1005.
老虎证券2026-05-07 12:33:59
Cathie Wood Continues to Support Elon Musk: SpaceX IPO Subscription Demand Is "Insatiable", Tesla (TSLA.US) Will Win the Autonomous Driving Race
金融界2026-05-08 08:05:23
The AGI timeline is being pushed back: Silicon Valley begins to reassess the real pace of AI
美股研究社2026-05-08 11:43:29
3 Space Stocks To Watch Amid Elon Musk’s SpaceX IPO Hype
BeInCrypto2026-05-08 19:45:29
Major Bank Ratings | Citi: BeiGene reports strong Q1 results, target price raised to $453
格隆汇2026-05-11 02:48:36
Tonix Pharmaceuticals Holding Co (TNXP) announced that it expects to launch a Phase 2 clinical trial of its candidate drug Tonmya for the treatment of major depressive disorder (MDD) in the middle of this year.
老虎证券2026-05-11 22:05:29
Another global pandemic on the way? Hantavirus concerns escalate, this stock soars 22% in two days
金融界2026-05-11 23:53:11
CRCL bucked the trend and surged, despite Circle's financial report falling short of expectations, as it unveiled two game-changing weapons to break the deadlock
Cointime2026-05-12 04:16:08
Meta Stock Price Prediction: Is META a Buy in 2026?
BlockchainReporter2026-05-14 01:01:05
The success or failure of OpenAI’s trillion-dollar IPO will be decided by an Oakland jury
金融界2026-05-18 07:47:17
US stocks move: Regeneron Pharmaceuticals falls 11.2% in pre-market trading after phase III clinical trial of melanoma drug fails
格隆汇2026-05-18 08:40:01
CervoMed announced plans to initiate a Phase III clinical trial in the second half of 2026 to evaluate the efficacy and safety of its candidate drug Neflamapimod in patients with dementia with Lewy bodies (DLB).
老虎证券2026-05-18 11:45:01
The latest data from Boston Scientific's Fracture clinical trial show that patients achieved a 93.3% rate of freedom from major adverse cardiovascular events during the critical 30-day postoperative observation period.
老虎证券2026-05-19 10:43:01
NKGen Biotech Inc. is expanding its Alzheimer’s disease clinical trial site network nationwide across the United States.
老虎证券2026-05-19 12:15:55
ImmunityBio, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Anktiva® (nogapendekin alfa inbakicept) in combination with BCG for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary disease.
老虎证券2026-05-20 00:56:31
Google To Hand Out $68,000,000 To Settle Accusations of Secretly Recording Users of Its AI-Powered Virtual Assistant
Dailyhodl2026-05-20 05:45:17
After Eli Lilly released trial data for its new-generation weight loss drug Retatrutide, Novo Nordisk's stock price dropped by up to 1.8%.
华尔街见闻2026-05-21 14:38:08
Biogen and Denali report that their Parkinson's disease drug did not meet the trial endpoint
老虎证券2026-05-21 23:23:04
The lung cancer combination therapy jointly developed by Merck and its partner Kelun Pharmaceutical has successfully achieved the primary endpoint in a pivotal late-stage clinical trial.
老虎证券2026-05-22 10:20:36
On the eve of IPO, Starship V3 completes its first successful test flight, SpaceX's trillion-dollar space AI empire crosses a critical threshold
金融界2026-05-23 01:32:25
Weight loss effect comparable to surgery! Eli Lilly RETA becomes the strongest "weight loss miracle drug" in history—"Will obesity become a rare disease in a few years?"
华尔街见闻2026-05-25 00:26:41
Eli Lilly will launch phase 2 recruitment for Verve-102 by the end of the year
华尔街见闻2026-05-25 12:50:34
Eli Lilly reports positive early results for its gene-editing cholesterol therapy
格隆汇2026-05-25 14:20:09
3 Space Stocks To Watch Amid Elon Musk’s SpaceX IPO Hype
BeInCrypto2026-05-08 19:45:29
Major Bank Ratings | Citi: BeiGene reports strong Q1 results, target price raised to $453
格隆汇2026-05-11 02:48:36
Tonix Pharmaceuticals Holding Co (TNXP) announced that it expects to launch a Phase 2 clinical trial of its candidate drug Tonmya for the treatment of major depressive disorder (MDD) in the middle of this year.
老虎证券2026-05-11 22:05:29
Another global pandemic on the way? Hantavirus concerns escalate, this stock soars 22% in two days
金融界2026-05-11 23:53:11
CRCL bucked the trend and surged, despite Circle's financial report falling short of expectations, as it unveiled two game-changing weapons to break the deadlock
Cointime2026-05-12 04:16:08
Meta Stock Price Prediction: Is META a Buy in 2026?
BlockchainReporter2026-05-14 01:01:05
The success or failure of OpenAI’s trillion-dollar IPO will be decided by an Oakland jury
金融界2026-05-18 07:47:17
US stocks move: Regeneron Pharmaceuticals falls 11.2% in pre-market trading after phase III clinical trial of melanoma drug fails
格隆汇2026-05-18 08:40:01
CervoMed announced plans to initiate a Phase III clinical trial in the second half of 2026 to evaluate the efficacy and safety of its candidate drug Neflamapimod in patients with dementia with Lewy bodies (DLB).
老虎证券2026-05-18 11:45:01
The latest data from Boston Scientific's Fracture clinical trial show that patients achieved a 93.3% rate of freedom from major adverse cardiovascular events during the critical 30-day postoperative observation period.
老虎证券2026-05-19 10:43:01
NKGen Biotech Inc. is expanding its Alzheimer’s disease clinical trial site network nationwide across the United States.
老虎证券2026-05-19 12:15:55
ImmunityBio, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Anktiva® (nogapendekin alfa inbakicept) in combination with BCG for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary disease.
老虎证券2026-05-20 00:56:31
Google To Hand Out $68,000,000 To Settle Accusations of Secretly Recording Users of Its AI-Powered Virtual Assistant
Dailyhodl2026-05-20 05:45:17
After Eli Lilly released trial data for its new-generation weight loss drug Retatrutide, Novo Nordisk's stock price dropped by up to 1.8%.
华尔街见闻2026-05-21 14:38:08
Biogen and Denali report that their Parkinson's disease drug did not meet the trial endpoint
老虎证券2026-05-21 23:23:04
The lung cancer combination therapy jointly developed by Merck and its partner Kelun Pharmaceutical has successfully achieved the primary endpoint in a pivotal late-stage clinical trial.
老虎证券2026-05-22 10:20:36
On the eve of IPO, Starship V3 completes its first successful test flight, SpaceX's trillion-dollar space AI empire crosses a critical threshold
金融界2026-05-23 01:32:25
Weight loss effect comparable to surgery! Eli Lilly RETA becomes the strongest "weight loss miracle drug" in history—"Will obesity become a rare disease in a few years?"
华尔街见闻2026-05-25 00:26:41
Eli Lilly will launch phase 2 recruitment for Verve-102 by the end of the year
华尔街见闻2026-05-25 12:50:34
Eli Lilly reports positive early results for its gene-editing cholesterol therapy
格隆汇2026-05-25 14:20:09
TSE:141A stock price change
On the last trading day, TSE:141A stock closed at 2805.00 JPY, with a price change of 0.07% for the day.
Trade stock perpsTSE:141A stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more